Atopic Dermatitis and Atopic Hand Eczema
Leo Pharma A/S focuses on inflammatory skin disease research centered on atopic dermatitis, including moderate-to-severe disease in adults, children, and infants. Its portfolio also includes work in atopic hand eczema, reflecting interest in difficult-to-treat eczematous conditions with substantial symptom burden and impact on daily function.
- Moderate-to-severe atopic dermatitis
- Atopic hand eczema
- Paediatric and infant skin disease
- Itch, scratching, and skin barrier function
Research activity in this area includes biologic and topical approaches aimed at controlling skin inflammation, improving lesion extent and symptom severity, and addressing quality-of-life effects in younger patients and caregivers.
Psoriasis and Palmoplantar Pustulosis
The sponsor has active interest in chronic psoriatic disease, including moderate-to-severe plaque psoriasis in people with high body weight and mild to severe palmoplantar pustulosis. These studies indicate a therapeutic emphasis on inflammatory dermatoses that can be persistent, functionally limiting, and difficult to manage on the hands and feet.
- Moderate-to-severe plaque psoriasis
- Palmoplantar pustulosis
- High body weight psoriasis populations
- Chronic inflammatory skin disorders
This area includes evaluation of treatment approaches for patients with substantial skin involvement and special clinical characteristics relevant to response in psoriasis.
Gout Flare and Autoinflammatory Disease
Leo Pharma A/S also funds research in acute gout flares, extending its therapeutic interests beyond dermatology into inflammatory pain and crystal-associated disease. The trial landscape suggests attention to autoinflammatory mechanisms and treatment options for sudden inflammatory episodes.
- Gout flares
- Acute inflammatory pain
- Autoinflammatory disease
- Pharmacokinetic characterization
Work in this domain reflects interest in therapies for episodic inflammation and conditions where rapid symptom control is clinically important.
Paediatric Dermatology
A substantial part of the sponsor’s research activity is directed toward children and infants with inflammatory skin disease, particularly moderate-to-severe atopic dermatitis. These studies address disease control across early life stages and the burden placed on family routines and well-being.
- Children with atopic dermatitis
- Infant skin disease
- Topical corticosteroid combination treatment
- Quality of life in paediatric care
Research in this field includes evaluation of skin symptoms, itching, and caregiver-relevant outcomes in younger populations with chronic inflammatory dermatoses.
